| Multi‐Omics Factor Analysis—a framework for unsupervised integration of multi‐omics data sets R Argelaguet, B Velten, D Arnol, S Dietrich, T Zenz, JC Marioni, F Buettner, ... Molecular systems biology 14 (6), e8124, 2018 | 807 | 2018 |
| Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study … P Dreger, H Döhner, M Ritgen, S Böttcher, R Busch, S Dietrich, D Bunjes, ... Blood, The Journal of the American Society of Hematology 116 (14), 2438-2447, 2010 | 397 | 2010 |
| Expression and mutational analysis of MET in human solid cancers PC Ma, MS Tretiakova, AC MacKinnon, N Ramnath, C Johnson, ... Genes, Chromosomes and Cancer 47 (12), 1025-1037, 2008 | 361 | 2008 |
| BRAF inhibition in refractory hairy-cell leukemia S Dietrich, H Glimm, M Andrulis, C Von Kalle, AD Ho, T Zenz New England Journal of Medicine 366 (21), 2038-2040, 2012 | 288 | 2012 |
| Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ... Leukemia 32 (8), 1768-1777, 2018 | 250 | 2018 |
| Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system T Luft, S Dietrich, C Falk, M Conzelmann, M Hess, A Benner, F Neumann, ... Blood, The Journal of the American Society of Hematology 118 (6), 1685-1692, 2011 | 223 | 2011 |
| p53-dependent non-coding RNA networks in chronic lymphocytic leukemia CJ Blume, A Hotz-Wagenblatt, J Hüllein, L Sellner, A Jethwa, T Stolz, ... Leukemia 29 (10), 2015 | 181 | 2015 |
| Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study LE Budde, LH Sehn, M Matasar, SJ Schuster, S Assouline, P Giri, ... The Lancet Oncology 23 (8), 1055-1065, 2022 | 172 | 2022 |
| Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation NW Choong, S Dietrich, TY Seiwert, MS Tretiakova, V Nallasura, ... Nature Clinical Practice Oncology 3 (1), 50-57, 2006 | 169 | 2006 |
| Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and … D Roos-Weil, S Dietrich, A Boumendil, E Polge, D Bron, E Carreras, ... Blood, The Journal of the American Society of Hematology 121 (3), 440-446, 2013 | 168 | 2013 |
| Drug-perturbation-based stratification of blood cancer S Dietrich, M Oleś, J Lu, L Sellner, S Anders, B Velten, B Wu, J Huellein, ... The Journal of clinical investigation 128 (1), 427-445, 2018 | 151 | 2018 |
| Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment S Dietrich, CS Falk, A Benner, S Karamustafa, E Hahn, M Andrulis, ... Biology of Blood and Marrow Transplantation 19 (1), 22-27, 2013 | 135 | 2013 |
| BRAF inhibition in hairy cell leukemia with low-dose vemurafenib S Dietrich, A Pircher, V Endris, F Peyrade, CM Wendtner, GA Follows, ... Blood, The Journal of the American Society of Hematology 127 (23), 2847-2855, 2016 | 127 | 2016 |
| TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial P Dreger, A Schnaiter, T Zenz, S Böttcher, M Rossi, P Paschka, A Bühler, ... Blood, The Journal of the American Society of Hematology 121 (16), 3284-3288, 2013 | 126 | 2013 |
| Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels T Roider, J Seufert, A Uvarovskii, F Frauhammer, M Bordas, N Abedpour, ... Nature cell biology 22 (7), 896-906, 2020 | 112 | 2020 |
| Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe … S Dietrich, SO Schönland, A Benner, T Bochtler, AV Kristen, J Beimler, ... Blood, The Journal of the American Society of Hematology 116 (4), 522-528, 2010 | 110 | 2010 |
| Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately … S Dietrich, M Andrulis, U Hegenbart, T Schmitt, F Bellos, UM Martens, ... Biology of Blood and Marrow Transplantation 17 (8), 1250-1254, 2011 | 107 | 2011 |
| Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations BH Durham, B Getta, S Dietrich, J Taylor, H Won, JM Bogenberger, ... Blood, The Journal of the American Society of Hematology 130 (14), 1644-1648, 2017 | 106 | 2017 |
| Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone T Bochtler, U Hegenbart, C Kunz, A Benner, A Seckinger, S Dietrich, ... Amyloid 21 (1), 9-17, 2014 | 102 | 2014 |
| Quantification of differential transcription factor activity and multiomics-based classification into activators and repressors: diffTF I Berest, C Arnold, A Reyes-Palomares, G Palla, KD Rasmussen, H Giles, ... Cell reports 29 (10), 3147-3159. e12, 2019 | 101 | 2019 |
Axel BennerDKFZ HeidelbergVerified email at dkfz-heidelberg.de
